What did they think? new study collects feedback on down syndrome drug
NCT ID NCT07413224
First seen Feb 21, 2026 · Last updated May 12, 2026 · Updated 11 times
Summary
This study asks people with Down syndrome and their caregivers who took part in an earlier trial of the drug AEF0217 to share their thoughts and experiences. Researchers want to understand how the treatment felt to them, using a simple questionnaire. The goal is to gather personal insights, not to test the drug itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOWN SYNDROME (TRISOMY 21) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital del Mar Research Institute
Barcelona, 08003, Spain
Conditions
Explore the condition pages connected to this study.